| Janssen-Cilag AG - Remicade, Lyophilisat |
| 55184 | | 01 | | Remicade | | Lyophilisat | | L04AB02 | | Infliximab | | 21.12.1999 | | |
|
| Composition |
| Praeparatio cryodesiccata: infliximabum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, saccharum, polysorbatum 80, pro vitro corresp. natrium 1.943 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Infliximab | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Infliximab | 100 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Dihydrate | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 506.30 | 565.50 | A | SL | Yes |
|
